| 000 | 01598 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516135850.0 | ||
| 264 | 0 | _c20130717 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1879-1891 | ||
| 024 | 7 |
_a10.1016/j.ajo.2013.01.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTu, Elmer Yuchen | |
| 245 | 0 | 0 |
_aTopical linezolid 0.2% for the treatment of vancomycin-resistant or vancomycin-intolerant gram-positive bacterial keratitis. _h[electronic resource] |
| 260 |
_bAmerican journal of ophthalmology _cJun 2013 |
||
| 300 |
_a1095-1098.e1 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAcetamides _xadministration & dosage |
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCorneal Ulcer _xdrug therapy |
| 650 | 0 | 4 |
_aEnterococcus faecalis _xdrug effects |
| 650 | 0 | 4 |
_aEye Infections, Bacterial _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLinezolid |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOphthalmic Solutions |
| 650 | 0 | 4 |
_aOxazolidinones _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aStaphylococcus _xdrug effects |
| 650 | 0 | 4 |
_aStreptococcus mitis _xdrug effects |
| 650 | 0 | 4 | _aVancomycin Resistance |
| 700 | 1 | _aJain, Sandeep | |
| 773 | 0 |
_tAmerican journal of ophthalmology _gvol. 155 _gno. 6 _gp. 1095-1098.e1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ajo.2013.01.010 _zAvailable from publisher's website |
| 999 |
_c22546138 _d22546138 |
||